NASDAQ:ANDS, MRNA, ZIOP - Active Biotechnology Stocks Losers

Penny Stock Pick Report alerts investors on Top Stocks that would help investors to generate higher than average returns. Subscribe to FREE Stock Alerts by visiting: http://www.pennystockpickreport.com/
 

Anadys Pharmaceuticals, Inc. (NASDAQ:ANDS) was one of the most active losers in today`s trading sessions as it plunged over 8.21% to end the day at $1.79 on huge volume of 376K shares after. The stock prices went down over 19% in last 5 trading sessions after the company reported its financial results and program highlights for the third quarter ended September 30, 2009. As of September 30, 2009, the Company's cash, cash equivalents and securities available-for-sale totaled $25.4 million compared to $27.9 million as of December 31, 2008.

MDRNA, Inc. (NASDAQ:MRNA) went down $0.01 or 0.96% to close at $1.03 on a volume of over 323K shares. The stock has a 52-week range of $0.21 to $3.55. So far the stock price jumped over 32% in last six months. MDRNA, Inc. is a biotechnology company focused on the discovery, development and commercialization of pharmaceuticals based on RNA interference. The Company’s infrastructure provides for pre-clinical scale manufacturing of both siRNAs and delivery materials, the comprehensive analysis and optimization of these compounds both individually and as drug candidates, and the filing of Investigational New Drug Applications.

ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) fell 3.74% to close at $3.09 on huge volume of 170K shares. The stock has a 52-week range of $0.50 to $4.10. So far the stock price jumped over 382% in last six months. ZIOPHARM Oncology, Inc. is a development-stage biopharmaceutical company. The Company focuses on developing and commercializing a portfolio of in-licensed cancer drugs that address unmet medical needs.